The Hartford Balanced Income Fund Class I (HBLIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
14.10
+0.04 (0.28%)
Jan 13, 2025, 4:00 PM EST
-0.98% (1Y)
Fund Assets | 13.45B |
Expense Ratio | 0.63% |
Min. Investment | $2,000 |
Turnover | n/a |
Dividend (ttm) | 1.04 |
Dividend Yield | 7.41% |
Dividend Growth | 106.84% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Dec 27, 2024 |
Previous Close | 14.06 |
YTD Return | -0.56% |
1-Year Return | 1.73% |
5-Year Return | 18.59% |
52-Week Low | 13.95 |
52-Week High | 15.35 |
Beta (5Y) | n/a |
Holdings | 1451 |
Inception Date | Feb 26, 2010 |
About HBLIX
The The Hartford Balanced Income Fund Class I (HBLIX) seeks to provide current income with growth of capital as a secondary objective. Under normal circumstances, the Fund will target an allocation of approximately 45% equity securities and 55% fixed income investments, with the allocation generally varying by no more than 5%.
Fund Family Hartford Funds I
Category Allocation--30% to 50% Equity
Performance Rating Above Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol HBLIX
Index Russell 1000 Value TR
Performance
HBLIX had a total return of 1.73% in the past year. Since the fund's inception, the average annual return has been 6.86%, including dividends.
Top 10 Holdings
13.54% of assetsName | Symbol | Weight |
---|---|---|
Usd | n/a | 2.61% |
JPMorgan Chase & Co. | JPM | 1.76% |
UnitedHealth Group Incorporated | UNH | 1.36% |
ConocoPhillips | COP | 1.31% |
Johnson & Johnson | JNJ | 1.20% |
Us Ultra Bond Cbt Mar25 Xcbt 20250320 | n/a | 1.14% |
2 Year Treasury Note Future Mar 25 | n/a | 1.07% |
Pfizer Inc. | PFE | 1.04% |
Gilead Sciences, Inc. | GILD | 1.03% |
Cisco Systems, Inc. | CSCO | 1.03% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 27, 2024 | $0.14519 | Dec 30, 2024 |
Dec 17, 2024 | $0.50283 | Dec 18, 2024 |
Sep 26, 2024 | $0.13142 | Sep 27, 2024 |
Jun 26, 2024 | $0.12705 | Jun 27, 2024 |
Mar 26, 2024 | $0.13837 | Mar 27, 2024 |
Dec 27, 2023 | $0.14903 | Dec 28, 2023 |